This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 18 print issues and online access
$259.00 per year
only $14.39 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Contributions
VM - extracted key data, designed infographic with text, refined content. LF - reviewed, fed back and approved final infographic. AK - reviewed, fed back and approved final infographic. DJF - reviewed, fed back and approved final infographic.
Corresponding author
Ethics declarations
Competing interests
LF and DJF are members of the Eye editorial board. The authors declare no other conflicts of interest.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Manikavasagar, V., Faes, L., Kennedy, A. et al. Infographic: Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW and RAINBOW Extension Study). Eye (2026). https://doi.org/10.1038/s41433-025-04187-1
Received:
Revised:
Accepted:
Published:
Version of record:
DOI: https://doi.org/10.1038/s41433-025-04187-1